What is Eikon Therapeutics, Inc. 's PP&E (net)?

Eikon Therapeutics, Inc. (EIKN) reported PP&E (net) of $138.07M in Q1 2026.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Kohl'sKSS

$6.78B-6.0%

HRO

HarrowHROW

$3.13M-12.3%

Flywire CorporationFLYW

$24.33M+39.9%

ImaxIMAX

$240.89M-1.7%

First Busey CorporationBUSE

$193.32M+6.2%

CalixCALX

$39M+26.5%

Operating income-$87.3M-22.3%

Net income-$83.0M-21.6%

EPS (diluted)-$2.46+90.9%

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total equity$550.7M+186%

Total assets$850.8M—

Operating cash flow-$89.8M-64.7%

CapEx$262.0K-98.8%

Free cash flow-$90.1M-17.1%

Market cap$514.86M—

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Eikon Therapeutics, Inc. 's PP&E (net)?: Eikon Therapeutics, Inc. (EIKN) reported PP&E (net) of $138.07M in Q1 2026.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.